NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN

被引:558
作者
Wang, Xinjiang
Trotman, Lloyd C.
Koppie, Theresa
Alimonti, Andrea
Chen, Zhenbang
Gao, Zhonghua
Wang, Junru
Erdjument-Bromage, Hediye
Tempst, Paul
Cordon-Cardo, Carlos
Pandolfi, Pier Paolo
Jiang, Xuejun
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cenc Biol & Genet Program, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA
关键词
D O I
10.1016/j.cell.2006.11.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or deleted frequently in various human cancers. Subtle reductions in PTEN expression levels have profound impacts on carcinogenesis. Here we show that PTEN level is regulated by ubiquitin-mediated proteasomal degradation, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. In cells NEDD4-1 negatively regulates PTEN stability by catalyzing PTEN polyubiquitination. Consistent with the tumor-suppressive role of PTEN, overexpression of NEDD4-1 potentiated cellular transformation. Strikingly, in a mouse cancer model and multiple human cancer samples where the genetic background of PTEN was normal but its protein levels were low, NEDD4-1 was highly expressed, suggesting that aberrant upregulation of NEDD4-1 can posttranslationally suppress PTEN in cancers. Elimination of NEDD4-1 expression inhibited xenotransplanted tumor growth in a PTENdependent manner. Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 42 条
  • [1] Adey NB, 2000, CANCER RES, V60, P35
  • [2] [Anonymous], 1983, COLD SPRING HARBOR L
  • [3] Destabilization of ΔNp63α by Nedd4-mediated ubiquitination and Ubc9-mediated sumoylation, and its implications on dorsoventral patterning of the zebrafish embryo
    Bakkers, J
    Camacho-Carvajal, M
    Nowak, M
    Kramer, C
    Danger, B
    Hammerschmidt, M
    [J]. CELL CYCLE, 2005, 4 (06) : 790 - 800
  • [4] Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding
    Blot, V
    Perugi, F
    Gay, B
    Prévost, MC
    Briant, L
    Tangy, F
    Abriel, H
    Staub, O
    Dokhélar, MC
    Pique, C
    [J]. JOURNAL OF CELL SCIENCE, 2004, 117 (11) : 2357 - 2367
  • [5] MDM2 is a central node in the p53 pathway: 12 years and counting
    Bond, GL
    Hu, WW
    Levine, AJ
    [J]. CURRENT CANCER DRUG TARGETS, 2005, 5 (01) : 3 - 8
  • [6] Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
    Brooks, CL
    Gu, W
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) : 164 - 171
  • [7] Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
    Chen, ZB
    Trotman, LC
    Shaffer, D
    Lin, HK
    Dotan, ZA
    Niki, M
    Koutcher, JA
    Scher, HI
    Ludwig, T
    Gerald, W
    Cordon-Cardo, C
    Pandolfi, PP
    [J]. NATURE, 2005, 436 (7051) : 725 - 730
  • [8] THE UBIQUITIN-MEDIATED PROTEOLYTIC PATHWAY AND MECHANISMS OF ENERGY-DEPENDENT INTRACELLULAR PROTEIN-DEGRADATION
    CIECHANOVER, A
    FINLEY, D
    VARSHAVSKY, A
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1984, 24 (01) : 27 - 53
  • [9] Pten is essential for embryonic development and tumour suppression
    Di Cristofano, A
    Pesce, B
    Cordon-Cardo, C
    Pandolfi, PP
    [J]. NATURE GENETICS, 1998, 19 (04) : 348 - 355
  • [10] Fostier M, 1998, GENETICS, V150, P1477